Bell & Brown Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-1,665
Closed -$230K – 70
2023
Q4
$230K Buy
+1,665
New +$219K 0.11% 68
2023
Q2
$238K Sell
1,690
-10
-0.6% -$1.38K 0.12% 66
2023
Q1
$241K Sell
1,700
-115
-6% -$16.5K 0.13% 65
2022
Q4
$284K Sell
1,815
-135
-7% -$19.4K 0.16% 66
2022
Q3
$239K Sell
1,950
-50
-3% -$6.58K 0.15% 62
2022
Q2
$266K Sell
2,000
-30
-1% -$4.09K 0.14% 69
2022
Q1
$278K Sell
2,030
-325
-14% -$45.3K 0.13% 67
2021
Q4
$323K Sell
2,355
-50
-2% -$7.61K 0.16% 62
2021
Q3
$349K Buy
+2,405
New +$352K 0.19% 62
2020
Q3
$307K Hold
2,475
– – 0.22% 62
2020
Q2
$315K Sell
2,475
-65
-3% -$6.89K 0.25% 63
2020
Q1
$278K Sell
2,540
-110
-4% -$11.4K 0.26% 66
2019
Q4
$284K Sell
2,650
-100
-4% -$10.4K 0.21% 72
2019
Q3
$293K Hold
2,750
– – 0.24% 70
2019
Q2
$280K Hold
2,750
– – 0.25% 72
2019
Q1
$247K Hold
2,750
– – 0.23% 76
2018
Q4
$229K Hold
2,750
– – 0.25% 73
2018
Q3
$259K Hold
2,750
– – 0.24% 78
2018
Q2
$302K Hold
2,750
– – 0.3% 73
2018
Q1
$283K Hold
2,750
– – 0.3% 76
2017
Q4
$271K Buy
+2,750
New +$261K 0.28% 73

Other funds holding DGX

Bell & Brown Wealth Advisors's DGX Position: Q1 2024 in Review

Bell & Brown Wealth Advisors sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 1,665 shares — an estimated $230K sold.

Bell & Brown Wealth Advisors first reported a position in DGX in Q4 2017 and held it in 21 quarters. The position peaked at $349K in Q3 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Bell & Brown Wealth Advisors reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Bell & Brown Wealth Advisors sold 1,665 Quest Diagnostics shares in Q1 2024, an estimated $230K.
  • Bell & Brown Wealth Advisors first reported a position in Quest Diagnostics in Q4 2017 and held it in 21 quarters.
  • Bell & Brown Wealth Advisors's Quest Diagnostics position peaked at $349K in Q3 2021.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Bell & Brown Wealth Advisors's 13F filing for Q1 2024, filed 13 May 2024.